Targeting FOLR1 in High-Risk CBF2AT3-GLIS2 AML with Stro-002 FOLR1-Directed Antibody-Drug Conjugate 2021 https://researcherprofiles.org/profile/376214067 Le Q, Smith JL, Tang TT, Castro S, Nourigat-Mckay C, Perkins L, Huang BJ, Ries RE, Leonti AR, Hylkema TA, Pardo L, Abrahams C, Bedard K, Molina A, Eidenschink Brodersen L, Loken MR, Meshinchi S
